Insulin glargine and lixisenatide Subcutaneous and Methocarbamol Tablets
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Methocarbamol Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: methocarbamol
Brand name: Robaxin, Robaxin-750, Carbacot, Skelex
Synonyms: Methocarbamol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Methohexital
- Insulin glargine and lixisenatide Subcutaneous-Methotrexate
- Insulin glargine and lixisenatide Subcutaneous-Methotrexate injection
- Insulin glargine and lixisenatide Subcutaneous-Methotrexate Injection (Subcutaneous)
- Insulin glargine and lixisenatide Subcutaneous-Methotrexate Oral Solution
- Insulin glargine and lixisenatide Subcutaneous-Methotrexate Oral, Injection
- Methocarbamol Tablets-Insulin glargine, recombinant Subcutaneous
- Methocarbamol Tablets-Insulin glulisine
- Methocarbamol Tablets-Insulin Glulisine (Cartridges and Pens)
- Methocarbamol Tablets-Insulin Glulisine (Vials)
- Methocarbamol Tablets-Insulin glulisine Subcutaneous
- Methocarbamol Tablets-Insulin human inhaled Inhalation